Chronic airway diseases
PG15 Postgraduate Course
Asthma stratification
Basic translational science
Registration for this session is additional to the congress registration fee and is €171 on site, €153 standard.
Aims : To present the innovations in asthma stratification that facilitate personalised therapeutic strategies. The specific aims are to highlight the importance of stratifying asthma patients for correct therapeutic approaches, explain the importance of both clinical and biomarker assesement in patient stratification, indicate the value of molecular stratification for understanding disease-driving mecanisms and hwo this may translate to nee therapies particularly for non-T2 asthma.
Target audience :
Allergologist, Clinician, Fellow, General practitioner, Immunologist, Junior member, Lung function technician, Occupational therapist, Pathologist, Pharmaceutical industry representative, Pulmonologist, Researcher, Resident, Respiratory physician, Scientist, Student, Trainee
14:00
The need for asthma phenotyping
L. Fleming(London, United Kingdom)
COI
-
Description
1
144
14:30
Biomarker-high patients, compliance, and steroid responsiveness
L. Heaney(Belfast (Belfast), United Kingdom)
COI
-
Description
2
145
15:00
Group assignment
3
146
16:00
Unbiased approaches to asthma stratification: the road to novel therapies
P. Sterk(Koudekerk aan den Rijn, Netherlands)
COI
-
Description
5
148
16:30
Patient stratification and targeted drug therapy: T2 asthma and beyond
G. Anderson(Parkville (VIC), Australia)
COI
-
Description
6
149
17:00
Group assignment
7
150
. . .
